Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SRPT stock hub

Sarepta Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SRPTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SRPT

In the news

Latest news · SRPT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21

P25 12.3P50 18.4P75 33.1

Trailing P/E31.3

P25 14.9P50 23.2P75 38.5

ROE4.9

P25 -105.6P50 -46.5P75 -3.1

ROIC0.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SRPT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

USD

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000873303
Company name	Sarepta Therapeutics, Inc.
Country	United States
Country code	US
Cusip	803607100
Employees	835
Employees Change	-537%
Employees Change Percent	-39.14
Enterprise value	$2.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1997-06-03
Isin	US8036071004
Last refreshed	2026-05-10
Market cap	$2.1B
Market cap category	Mid-Cap
Price	$19.96
Price currency	USD
Rev Per Employee	2,615,789.22x
Sector	Healthcare
Sic	2834
Symbol	SRPT
Website	https://www.sarepta.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.09%
EV Earnings	38.44x
EV Sales Forward	1.49x
EV/EBIT	2,388.38x
EV/EBITDA	54.14x
EV/FCF	21.77x
EV/Sales	1.14x
FCF yield	5.45%
Forward P/E	20.99x
P/B ratio	1.4x
P/E ratio	31.29x
P/S ratio	0.96x
PS Forward	1.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.05%
EBITDA Margin	2.11%
FCF margin	5.26%
Gross margin	-6.49%
Gross Profit	$-141.7M
Gross Profit Growth Q	3.69%
Net Income	$65.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	1.12%
Profit Margin	2.98%
Profit Per Employee	$77,913
ROA	0.02
Roa5y	-6.49
ROCE	0.04
ROE	4.91
Roe5y	-55.33
ROIC	0.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.21%
Cagr15y	4.41%
Cagr1y	-45.68%
Cagr20y	-3.08%
Cagr3y	-46.59%
Cagr5y	-23.18%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-2.2x
Revenue Growth Q	-1.89x
Revenue Growth Years	10x
Revenue Growth3 Y	30.82x
Revenue Growth5 Y	30.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.66
Assets	$3.2B
Cash	$653.2M
Current Assets	$2.3B
Current Liabilities	$499.2M
Debt	$1B
Debt EBITDA	$5.15
Debt Equity	$0.7
Debt FCF	$9.11
Equity	$1.5B
Interest Coverage	0.02
Liabilities	$1.7B
Long Term Assets	$869.1M
Long Term Liabilities	$1.2B
Net Cash	$-393.9M
Net Cash By Market Cap	$-18.69
Net Debt EBITDA	$8.53
Net Debt Equity	$0.26
Net Debt FCF	$3.43
Tangible Book Value	$1.5B
Tangible Book Value Per Share	$13.96
WACC	5.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.63
Inventory Turnover	2.39
Net Working Capital	$1.2B
Quick ratio	2.41
Working Capital	$1.8B
Working Capital Turnover	$1.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.78%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	12.74%
1Y total return	-45.66%
200-day SMA	19.86
3Y total return	-84.77%
50-day SMA	19.85
50-day SMA vs 200-day SMA	50under200
5Y total return	-73.24%
All Time High	181.8
All Time High Change	-89.03%
All Time High Date	2020-12-22
All Time Low	2.6
All Time Low Change	667.5%
All Time Low Date	2012-05-18
ATR	1.24
Beta	0.25
Beta1y	1.04
Beta2y	1.16
Ch YTD	-7.27
High	20.84
High52	44.14
High52 Date	2025-05-21
High52ch	-54.79%
Low	19.87
Low52	10.42
Low52 Date	2025-07-24
Low52ch	91.6%
Ma50ch	0.54%
Premarket Change Percent	0.77
Premarket Price	$20.96
Premarket Volume	12,852
Price vs 200-day SMA	0.47%
RSI	44.32
RSI Monthly	30.72
RSI Weekly	45.42
Sharpe ratio	-0.06x
Sortino ratio	-0.03
Total Return	-10.78%
Tr YTD	-7.27
Tr15y	91.14%
Tr1m	-13.54%
Tr1w	-7.14%
Tr3m	7.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	29
Analyst Count Top	8
Analyst Price Target Top	$29.17
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$0.91
Earnings Revenue Estimate	473,575,592x
Earnings Revenue Estimate Growth	-36.42x
Operating Income	$1M
Operating margin	0.05
Price target	$25.85
Price Target Change	$29.54
Price Target Change Top	$46.18

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	93,469,779%
Float Percent	88.53%
Net Borrowing	-159,378,000
Shares Insiders	4.12%
Shares Institutions	82.27%
Shares Out	105,576,222
Shares Qo Q	16.34%
Shares Yo Y	10.78%
Short Float	27.1%
Short Ratio	7.67
Short Shares	24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$3.5M
Average Volume	2,823,504.8x
Bv Per Share	14.26
CAPEX	$-60.4M
Ch10y	12.74
Ch15y	91.14
Ch1m	-13.54
Ch1w	-7.14
Ch1y	-45.66
Ch20y	-46.53
Ch3m	7.87
Ch3y	-84.77
Ch5y	-73.24
Ch6m	13.19
Change	-4.06%
Change From Open	-3.83
Close	20.8
Days Gap	-0.24
Depreciation Amortization	45,137,000
Dollar Volume	81,384,591.7
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$1M
EBITDA	$46.2M
EPS	$0.64
F Score	6
FCF	$114.9M
FCF EV Yield	4.59x
FCF Per Share	$1.09
Financing CF	-180,574,000
Fiscal Year End	December
Founded	1,980
Graham Number	14.30185
Graham Upside	-28.33
Income Tax	$-40.6M
Investing CF	226,428,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2012-07-12
Last Split Type	Reverse
Last10k Filing Date	2026-03-02
Ma150	20.46
Ma150ch	-2.46%
Ma20	21.23
Ma20ch	-6%
Net CF	221,129,000
Next Earnings Date	2026-08-05
Open	20.75
Optionable	Yes
P FCF Ratio	18.34
P OCF Ratio	12.02
Position In Range	8.76
Post Close	19.96
Postmarket Change Percent	0.08
Postmarket Price	$19.97
Ppne	460,300,000
Pre Close	20.8
Price Date	2026-05-08
Price EBITDA	$45.62
Ptbv Ratio	1.43
Relative Volume	1.44x
Revenue	2,184,184,000x
SBC By Revenue	5.1x
Share Based Comp	111,367,000
Tax By Revenue	-1.86x
Tr20y	-46.53%
Tr6m	13.19%
Us State	Massachusetts
Volume	4,078,406
Z Score	0.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SRPT pay a dividend?

Capital-return profile for this ticker.

Performance

SRPT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SRPT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.3%

Float: +88.5% of shares outstanding

Insider ownership

+4.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SRPT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.3

Neutral momentum band

Price vs 200-day MA

+0.5%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

-0.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SRPT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SRPT stock rating?

Sarepta Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SRPT analysis?

The full report lives at /stocks/SRPT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SRPT?

The latest report frames SRPT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SRPT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.